Home - Gastroenterology Advisor
Colonoscopy Prep and Other Quality Indicators for CRC Screening From ACG/ASGE. The American College of Gastroenterology and the American Society for Gastrointestinal Endoscopy Quality Task force have released updated guidance on quality indicators for colonoscopy.
Clinician Insights on How to Manage Semaglutide-Induced …
Sep 8, 2023 · Patients who receive treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist, such as semaglutide, may experience delayed gastric emptying due to the drug’s mechanism of action (MOA). 1 Symptoms may include nausea, vomiting, heartburn, pain, or bloating. 2 However, the symptoms of delayed gastric emptying resulting from GLP-1 receptor agonists may be similar to symptoms of ...
Gastric Intestinal Metaplasia: 2020 AGA Guidelines
Mar 12, 2020 · 5. Gupta S et al. AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology. 2020;158 (3):693-702. 6. Gawron AJ, Shah SC, Altayar O, et al. AGA technical review on gastric intestinal metaplasia—natural history and clinical outcomes. Gastroenterology. 2020;158 (3):705-731. 7.
What We Know About Semaglutide Adverse Events and …
Sep 1, 2023 · There were no reports of gastroparesis in the study. 1. While semaglutide and other GLP-1 agonists cause adverse events, such as nausea, vomiting, diarrhea, and a range of other GI symptoms, these effects of delayed gastric emptying are reported to be reduced after 20 weeks of use. 2. [T]here are some cases where gastroparesis may resolve if ...
Assessment of Antispasmodics Available in North America for the ...
Oct 15, 2021 · Data on the use of antispasmodics available in North America for the treatment of chronic abdominal pain in patients with disorders of gut-brain interaction (DGBI) vary dramatically in safety and efficacy, according to a literature review published in The American Journal of Gastroenterology.Overall, data supporting the use of antispasmodics in …
Hemorrhoid Treatment: ASCRS Issues Updated Clinical Practice …
May 3, 2024. The American Society of Colon and Rectal Surgeons (ASCRS) has updated its clinical practice guidelines for managing hemorrhoids. The report was published in Diseases of the Colon & Rectum. The updated guidelines, intended for practitioners, health care workers, and patients, address hemorrhoid diagnosis and treatment.
Acute Pancreatitis Management: Guidelines From the American …
April 26, 2024. The American College of Gastroenterology (ACG) has released guidelines about the management of acute pancreatitis (AP) in The American Journal of Gastroenterology. In the United States, AP accounts for more than 1 million patient days in the hospital and more than $2.5 billion in health care costs.
Will Vonoprazan Be the New First-Line Erosive Esophagitis …
Feb 23, 2024 · Evidence for Vonoprazan. Prior to this approval, a systematic review and network meta-analysis 6 of vonoprazan therapy trials had shown favorable results — comparable to those of PPIs — in resolving early heartburn symptoms of EE. Moreover, that study reported a numerically greater rate of heartburn symptom resolution on day 1 of treatment and a statistically greater rate of symptom ...
Gastroparesis Awareness Month: Updated Guidelines to Treat …
Aug 19, 2022 · The American College of Gastroenterology (ACG) released updated clinical guidelines on managing gastroparesis (GP). The new recommendations were published in The American Journal of Gastroenterology.. GP is characterized by delayed gastric emptying (GE) of solid food in the absence of mechanical obstruction.
Antidepressants for IBS: What Gastroenterologists Need to Know
Apr 5, 2024 · The 2021 American College of Gastroenterology (ACG) guideline update for IBS management 3 states that tricyclic antidepressants (TCAs) — also referred to as neuromodulators — may be used to manage global IBS symptoms. Clinicians can recommend gut-directed psychotherapies to patients with IBS after weighing their safety and efficacy, as well ...